Skin diseases can be very complex and may originate from various causes, including immune disorders, environmental influences, or genetic factors. Often, traditional treatments such as ointments, creams, or medications do not yield the desired results. In such cases, we can turn to innovative treatment with mesenchymal stem/stromal cells (MSCs), offering new hope for patients with skin diseases.
MSC therapies have attracted attention for their exceptional capabilities in dermatology. These cells are not only capable of regenerating and repairing damaged tissue, but also have the ability to regulate the body's immune system, which is particularly beneficial in diseases resulting from immune disorders. In addition, MSCs have the ability to differentiate into various cell types, meaning they can actively contribute to the repair of different skin structures.
Using MSC therapies can potentially improve the appearance and health of the skin, reduce symptoms such as inflammation, redness, or itching, and even achieve long-term improvement in chronic conditions. For example, in patients with psoriasis, where traditional treatments often only alleviate symptoms, MSC therapy can be a breakthrough and help.
With such promising results, MSC therapies represent a revolutionary approach in dermatology that can bring significant improvements to the quality of life for many patients. Research and clinical trials continue to explore the potential of this therapy, indicating that the future of treating skin diseases is even brighter.
MSC are multipotent cells that can differentiate into mesodermal cell lineages, such as adipocytes, osteocytes, and chondrocytes. MSC were initially isolated from bone marrow, but it is now known that they are found in almost all tissues (e.g., adipose tissue, umbilical cord, etc.). MSC have the ability to migrate to the site of injury in the body, where they can differentiate and replace damaged cells, as well as promote tissue regeneration. Additionally, they have the capacity for paracrine signaling and cell-to-cell communication by secreting various soluble factors and extracellular vesicles. In an inflammatory environment, they act immunomodulatory on different cells of the innate and adaptive immune systems, which is one of their main properties exploited for therapeutic purposes.
They can be used for local tissue regeneration or for their systemic effects.
It is important to know that PRP treatment is not the same as our therapy. PRP treatment uses only 1 to 3 stem cells, while our therapy uses a dosed amount of 15 to 20 million stem cells.
We at GaiaCell are a biotechnology company specialized in safe and effective cell therapies in orthopedics, hematooncology, pulmonology and other therapeutic areas. Our high-tech laboratories with GMP certificate and research center guarantee the highest quality and innovation. We also offer contract development and manufacturing (CDMO), ensuring top-notch project execution.